SCHEMBL7420896

SCHEMBL7420896

CCCc1c(C(=O)COC)c2ccc(C(N)=O)cc2n1Cc1ccc(Cl)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
OXER1 Q8TDS5 2/20 0.37
IP6K1 Q92551 1/20 0.37
PPARG P37231 1/20 0.37
MAPK1 P28482 1/20 0.36
NLRP1 Q9C000 1/20 0.36
MAPT P10636 2/20 0.36
ALDH1A1 P00352 1/20 0.36
ALOX12 P18054 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PLA2G2A P14555 3/20 0.35
GAA P10253 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7424199 0.91 PLA2G2A (0.34) LMNASMN1; SMN2OXER1PLA2G2ATSHR
SCHEMBL7422341 0.91 TP53 (0.41) SMN1; SMN2MAPTPLA2G2A
SCHEMBL7426312 0.91 OXER1 (0.36) OXER1PLA2G2A
SCHEMBL7423692 0.90 ALOX5AP (0.41) MAPTALDH1A1PLA2G2ACYP1A2CYP3A4
SCHEMBL7426123 0.86 SLC22A12 (0.39) LMNASMN1; SMN2MAPK1MAPTPLA2G2A
SCHEMBL7420996 0.86 LMNA (0.40) LMNASMN1; SMN2OXER1IP6K1PPARG
SCHEMBL7425576 0.82 MAPT (0.39) SMN1; SMN2MAPTPLA2G2A
SCHEMBL7471716 0.82 ALOX5AP (0.41) LMNAMAPK1MAPTALDH1A1PLA2G2A
SCHEMBL7421847 0.80 ALOX5AP (0.43) MAPTALDH1A1PLA2G2ACYP1A2CYP3A4
SCHEMBL7424518 0.79 ALOX5AP (0.43) MAPTALDH1A1PLA2G2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed